Eric Faulkner
Vermogen: 13 815 $ op 31-07-2026
Vermogen: 13 815 $ op 31-07-2026
Eric Faulkner is Chief Technology Officer at CNS Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Faulkner was Chief Technical Officer at IO Biotech, Inc. Education includes an MBA from Boston University and graduate studies at the University of Massachusetts.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-08-2026 | 2.375 ( 0,16% ) | 13 815 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-03-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IO BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
IO Biotech, Inc.
IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau